Consolidated Balance Sheets (USD $)	Dec. 31, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 90,192	$ 250,723
Accounts receivable, net	0	26,735
Inventories	202,077	367,838
Deferred debt issuance costs	165,649	0
Prepaid expenses and other current assets	191,030	24,493
Total current assets	648,948	669,789
Fixed assets, net	85,592	244,275
Patents, net	1,678,787	2,432,732
TOTAL ASSETS	2,413,327	3,346,796
Current liabilities:
Accounts payable	861,698	695,809
Convertible debt	1,129,473	0
Discount	(520,851)	0
Convertible debt, net	608,622	0
Derivative liability	2,335,560	0
Accrued expenses	183,855	145,356
Total current liabilities	3,989,735	841,165
COMMITMENTS
SHAREHOLDERS' EQUITY (DEFICIT)
Common stock, $.01 par value: Authorized - 275,000,000 shares Issued and outstanding -152,229,665 and 108,041,084 shares at December 31, 2012 and 2011, respectively	1,522,297	1,080,411
Additional paid-in capital	35,491,603	30,922,930
Accumulated deficit	(38,626,158)	(29,533,560)
TOTAL SHAREHOLDERS' EQUITY (DEFICIT)	(1,576,408)	2,505,631
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)	2,413,327	3,346,796
Series B Convertible Preferred Stock
SHAREHOLDERS' EQUITY (DEFICIT)
Convertible Preferred Stock, value	25,850	25,850
Series C Convertible Preferred Stock
SHAREHOLDERS' EQUITY (DEFICIT)
Convertible Preferred Stock, value	$ 10,000	$ 10,000